FDA drug approvals mostly flat in 2009

Drug approvals from the Food and Drug Administration were flat last year compared with 2008 and warnings fell, even as the agency’s new leadership struck a tougher stance on safety.

The FDA approved 26 first-of-a-kind prescription drugs last year, up slightly from 25 in 2008, according to figures from Washington Analysis, an investment research group. New drugs cleared in 2009 included Novartis’ kidney cancer drug Afinitor and Bausch and Lomb’s pink eye medicine Besivance.

Chris Penfold – there are a number of reasons froi this trend, one of them being a reduced number odf applications – so we can’t read too much in to this report.

Sourced from Pharmaceutical & Medical News, 6th January 2010 – Washington, USA

Read the full article at: Pharmaceutical & Medical Packaging News

Tags: , , , , , ,

This entry was posted on Wednesday, January 6th, 2010 at 8:38 am and is filed under Business News, Government, Healthcare & Pharma, Legal, Product News. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.

One Comment

  1. Matt says:
    July 28, 2014 at 12:39 am

    July 2015

  2. September 2014
  3. August 2014
  4. July 2014
  5. April 2014
  6. September 2013
  7. March 2013
  8. February 2013
  9. July 2012
  10. January 2012
  11. December 2011
  12. November 2011
  13. August 2011
  14. April 2011
  15. March 2011
  16. February 2011
  17. January 2011
  18. December 2010
  19. November 2010
  20. October 2010
  21. September 2010
  22. August 2010
  23. July 2010
  24. June 2010
  25. May 2010
  26. April 2010
  27. March 2010
  28. February 2010
  29. January 2010
  30. December 2009
  31. November 2009
  32. October 2009
  33. September 2009
  34. August 2009
  35. July 2009
  36. June 2009
  37. May 2009

  38. Tag Bag

  39. Tag Cloud

  40. Twitter Feed

    Posting tweet...